New Agent: 'First Step' Toward Delaying Progression of Type 1 Diabetes 

Dr Anne Peters discusses the approval of teplizumab and its potential impact in delaying the onset of stage 3 diabetes for patients age 8 years or older who currently have stage 2 type 1 diabetes. www.medscape.c...